Skip to content

Drug interactions

Lapatinib + Stiripentol

Severity: Moderate

Lapatinib and Stiripentol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Stiripentol inhibits and also induces CYP3A4 and inhibits P-glycoprotein, so lapatinib exposure may change unpredictably. Increased exposure raises the risk of toxicity, while induction could reduce antitumor efficacy.

What this interaction means in plain words

Lapatinib and Stiripentol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Stiripentol belongs to Central Nervous System.

Evidence level: Low

Why it happens

Stiripentol has mixed CYP3A4 inhibitory and inductive effects and inhibits P-gp, altering lapatinib disposition.

What to do

Monitor lapatinib tolerability (diarrhea, liver tests, QTc) and treatment response. Adjust the lapatinib dose if toxicity or loss of effect occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Stiripentol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Stiripentol?

MediHelp rates the interaction as moderate. Lapatinib and Stiripentol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Stiripentol inhibits and also induces CYP3A4 and inhibits P-glycoprotein, so lapatinib exposure may change unpredictably. Increased exposure raises the risk of toxicity, while induction could reduce antitumor efficacy.

How serious is the interaction between Lapatinib and Stiripentol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor lapatinib tolerability (diarrhea, liver tests, QTc) and treatment response. Adjust the lapatinib dose if toxicity or loss of effect occurs.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in